ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 214 filers reported holding ROYALTY PHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,731,532 | -11.4% | 63,800 | +0.3% | 0.02% | -7.4% |
| Q2 2023 | $1,955,064 | -18.2% | 63,600 | -4.1% | 0.03% | -22.9% |
| Q1 2023 | $2,388,789 | -8.8% | 66,300 | 0.0% | 0.04% | -16.7% |
| Q4 2022 | $2,620,176 | -0.7% | 66,300 | +0.9% | 0.04% | -4.5% |
| Q3 2022 | $2,639,000 | -4.1% | 65,700 | +0.3% | 0.04% | 0.0% |
| Q2 2022 | $2,753,000 | +21.9% | 65,500 | +12.9% | 0.04% | +46.7% |
| Q1 2022 | $2,259,000 | -3.9% | 58,000 | -1.7% | 0.03% | +3.4% |
| Q4 2021 | $2,351,000 | +10.6% | 59,000 | +0.3% | 0.03% | 0.0% |
| Q3 2021 | $2,125,000 | -15.8% | 58,800 | -4.5% | 0.03% | -12.1% |
| Q2 2021 | $2,525,000 | -5.7% | 61,600 | +0.3% | 0.03% | -10.8% |
| Q1 2021 | $2,678,000 | +153.6% | 61,400 | +191.0% | 0.04% | +146.7% |
| Q4 2020 | $1,056,000 | – | 21,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |